SDGR Q4 2022 Earnings — Schrödinger, Inc. Revenue & Financial Results | Market Cap Arena

SDGRSchrödinger, Inc.

$935M

Q4 2022 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$57M+23.1% YoY

Gross Profit

$39M68.1% margin

Operating Income

-$29M-50.2% margin

Net Income

-$27M-47.9% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

+53.7%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$26M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$689M

Total Liabilities

$241M

Stockholders' Equity

$448M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$46M	+23.1%
Gross Profit	$39M	$26M	+46.8%
Operating Income	-$29M	-$23M	-26.8%
Net Income	-$27M	-$31M	+11.4%

Revenue Segments

On Premise Software

$34M50%

Drug Discovery

$10M15%

Software Products And Services

$8M12%

Maintenance

$5M8%

Professional Services

$5M7%

Hosted Software

$4M6%

Drug Discovery Services

$2M3%